Literature DB >> 17564920

Autopsy-confirmed Alzheimer's disease versus clinically diagnosed Alzheimer's disease in the Cache County Study on Memory and Aging: a comparison of quantitative MRI and neuropsychological findings.

Michael A Fearing1, Erin D Bigler, Maria Norton, Jo Ann Tschanz, Christine Hulette, Carol Leslie, Kathleen Welsh-Bohmer.   

Abstract

Atrophy of specific, regional, and generalized brain structures occurs as a result of the Alzheimer's disease (AD) process. Comparing AD patients with histopathological confirmation of the disease at autopsy to those without autopsy but who were clinically diagnosed using the same antemortem criteria will provide further evidence of the utility and accuracy of neuropsychological assessments at the time of diagnosis, as well as the efficacy of quantitative magnetic resonance imaging (qMRI) in demonstrating gross neuropathological changes associated with the disease. The Cache County Study of Aging provides a unique opportunity to determine how closely AD subjects with only the clinical diagnosis match similarly diagnosed AD subjects but with postmortem confirmation of the disease. qMRI volumes of various brain structures, as well as neuropsychological outcome measures from an expanded battery, were obtained in 31 autopsy-confirmed AD subjects and 45 clinically diagnosed AD subjects. Of the various qMRI variables examined, only total temporal lobe volume was different, where those with postmortem confirmation had reduced volume. No significant differences between the two groups were found with any of the neuropsychological outcome measures. These findings confirm the similarity in neuroimaging and neuropsychological assessment findings between those with just the clinical diagnosis of AD and those with an autopsy-confirmed diagnosis in the moderate-to-severe stage of the disease at the time of diagnosis.

Entities:  

Mesh:

Year:  2007        PMID: 17564920     DOI: 10.1080/13803390600826579

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  5 in total

1.  Longitudinal epidemiologic clinical-pathologic studies of aging and Alzheimer's disease.

Authors:  David A Bennett; Lenore J Launer
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

2.  Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study.

Authors:  Huibo Shao; John C S Breitner; Rachel A Whitmer; Junmin Wang; Kathleen Hayden; Heidi Wengreen; Chris Corcoran; Joann Tschanz; Maria Norton; Ron Munger; Kathleen Welsh-Bohmer; Peter P Zandi
Journal:  Neurology       Date:  2012-10-24       Impact factor: 9.910

3.  Group-Level Progressive Alterations in Brain Connectivity Patterns Revealed by Diffusion-Tensor Brain Networks across Severity Stages in Alzheimer's Disease.

Authors:  Javier Rasero; Carmen Alonso-Montes; Ibai Diez; Laiene Olabarrieta-Landa; Lakhdar Remaki; Iñaki Escudero; Beatriz Mateos; Paolo Bonifazi; Manuel Fernandez; Juan Carlos Arango-Lasprilla; Sebastiano Stramaglia; Jesus M Cortes
Journal:  Front Aging Neurosci       Date:  2017-07-07       Impact factor: 5.750

4.  Accelerating regional atrophy rates in the progression from normal aging to Alzheimer's disease.

Authors:  Jasper D Sluimer; Wiesje M van der Flier; Giorgos B Karas; Ronald van Schijndel; Josephine Barnes; Richard G Boyes; Keith S Cover; Sílvia D Olabarriaga; Nick C Fox; Philip Scheltens; Hugo Vrenken; Frederik Barkhof
Journal:  Eur Radiol       Date:  2009-07-18       Impact factor: 5.315

Review 5.  Magnetic Resonance Imaging to Detect Early Molecular and Cellular Changes in Alzheimer's Disease.

Authors:  Michael J Knight; Bryony McCann; Risto A Kauppinen; Elizabeth J Coulthard
Journal:  Front Aging Neurosci       Date:  2016-06-16       Impact factor: 5.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.